• Yuncong Zhang, He Dong, Xue Zhang, and Juntao Wang.
• Department of Anesthesiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Anesthesia and Respiratory Critical Medicine, Jinan, China.
• Medicine (Baltimore). 2024 Jan 5; 103 (1): e36687e36687.

RationaleLiving donor allogeneic liver transplantation is a surgical treatment for patients with end-stage liver disease, wherein a healthy liver is implanted in the patient, facilitating the recovery of the liver function in patients with end-stage liver disease. However, primary nonfunction (PNF) may occur as a result of this procedure.Patient ConcernsA case of an 65-year-old Asian male with a medical history of cirrhosis and hepatocellular carcinoma is described. Intractable hypotension occurred after open hepatic portal anastomosis, and large doses of vasoactive substances did not improve the condition.DiagnosisPNF was diagnosed during surgery and it caused intractable hypotension.Interventionswe promptly used the total portosystemic shunt to achieve a successful rescue.OutcomesThe strengthening of perioperative management and active treatment allowed second liver transplantation and anhepatic phase of up to 10 hours, following which the patient was rescued.LessonsThe lesson we have learned is that total portosystemic shunt composited with careful anesthesia management can rescue the event of PNF with intractable hypotension in liver transplantation surgery. At the same time, we give attention to blood pressure, electrocardiogram, albumin, calcium, potassium, acidosis, coagulopathy, anti-infection, and protection of vital organs is essential for successful retransplant outcomes.Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

33 keywords...

hide…